Simple supplement may slow vision loss in rare eye disease
NCT ID NCT07342439
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tests whether taking serine, a natural amino acid, twice a day can slow vision loss in people with MacTel type 2, a rare eye disease. About 120 participants will receive either serine or a placebo for 24 months, with regular eye exams and imaging. The study aims to see if serine safely reduces damage to the retina.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACULAR TELANGIECTASIA TYPE 2 (MACTEL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cerulea- RVEEH
Melbourne, Victoria, 3002, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hamilton Glaucoma Center- UCSD
La Jolla, California, 92093, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Moorfields Eye Hospital
London, EC1V 2PD, United Kingdom
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oxford Eye Hospital
Oxford, OX3 9DU, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Radboud University Medical Center
Nijmegen, 6525GA, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Retina Associates Of Cleveland, Inc.
Cleveland, Ohio, 44122, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Save Sight Institute
Sydney, New South Wales, 2000, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St. Franziskus Hospital
Münster, 48145, Germany
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Bonn
Bonn, 53127, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Freiburg, Department of Ophthalmology
Freiburg im Breisgau, 79106, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Michigan, Kellogg Eye Center
Ann Arbor, Michigan, 48105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Utah Health Care, Moran Eye Center
Salt Lake City, Utah, 84132, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact